Dissertation > Excellent graduate degree dissertation topics show

Velcade and Autologous Hemapoietic Stem Cell Transplantation in Multiple Myeloma: A Case Report and Review of the Literature

Author: YanYangYang
Tutor: ZhangXiaoHong
School: Zhejiang University
Course: Department of Hematology
Keywords: Multiple myeloma autologous hemapoietic stem cell transplantation velcade
CLC: R733.3
Type: Master's thesis
Year: 2011
Downloads: 61
Quote: 0
Read: Download Dissertation

Abstract


BackgroudMultiple myeloma is the second high-risk malignant tumor in the hematology.The tranditional chemotherapy is inefficient, and autolougous hemapoietic stem cell transplantation becomes the fisrt line therapy in the patients who is under 65 years old so far. With the new drugs, the therapy of multiple myeloma has been developed rapidly. The effect of regiment concluding velcade and autolougous hemapoietic stem cell transplantion is summarized in this paper.ObjectiveImproving the cognition of multiple myeloma and the effect of the following regimen which is consisted of velcade and HD-Melphan supported by autologous stem cell transplantation.MethodsReport the enduring course of one MM patient with the regimen of HD-Melphan supported by autologous hemapoietic stem cell transplantation and velcade, and the related literature reviewed.ResultsThe patient complaining chest、wrest and back pains as the first symptom was diagnosed as multiple myeloma(IgA IIIA).There was no response after three courses of VAD regimen. The patient achieves VGPR with one cycle treatmemt of velcade regimen, then he achieve CR through pretreatment of high-dose melphalan and following an autologous stem cell transplantation.After 15 months, the paitient relapsed and retrieved again by re-use of a regiment including velcade.ConclusionDuring the induction and pro-transplantation treatment of the MM patient who is available for the autologous stem cell transplatation, the regimen including velcade can attain good effect. So, the regimen containing velcade and transplantation in newly diagnosed MM should be studied further.

Related Dissertations

  1. Exploration of the Risk Factors and Assessment on the Clinical Staging Systems of Patients with Multiple Myeloma,R733.3
  2. Immunophenotype and Genetic Abnormalities Analysis in Multiple Myeloma,R733.3
  3. Clinical Study of BDT and VADT on Multiple Myeloma,R733.3
  4. The Relation of Gambogic Acid’s Anti-proliferation Effect and HERG Expression in Multiple Myeloma,R733.3
  5. Mechanism Activities of NF-κB Pathway Inhibition by Parthenolide Via Ubiquitination in Multiple Myeloma,R733.3
  6. Multiple Myeloma Cells Derived Microvesicles: A Novel Efficient Way to Promote Myeloma Proliferation,R733.3
  7. Mutliple Myeloma-derived Microvesicles: A Novel Way to Promote Myeloma Angiogenesis,R733.3
  8. The Study of Multiple Osseous Metastases and Multiple Myeloma Applying WB-DWI,R738.1
  9. Experimental study of multiple myeloma thrombosis related factors,R733.3
  10. Effect of Inducing Apoptosis of Betulinic Acid on Human Multiple Myeloma Cell Line RPMI-8226,R733.3
  11. Studies Toward Synthesis of Melphalan Hydrochloride,TQ463.2
  12. Multiple myeloma molecular cytogenetic techniques and cytogenetic abnormalities research,R733.3
  13. Investigation of Molecular Cytogenetics in Patients with Multiple Myeloma Using Interphase Fluorescence in Situ Hybridization,R733.3
  14. The Expression and Clinical Significance of Pi3k Signaling Pathway in Multiple Myeloma,R733.3
  15. Bortezomib Effects Proliferation and Apoptosis on Osteoblast in Myeloma Bone Disease,R733.3
  16. The Expression and Significance of Medullary System Antigens in Multiple Myeloma,R733.3
  17. Study on Clinical and Laboratory Features of 169 Newly Diagnosed Multiple Myeloma Cases in Changchun,R733.3
  18. The Construction of Survivin shRNA Lentiviral Vector,R733.3
  19. The Clinical Efficacy Observation of Moldified VAD Regimen in Theatment of Multiple Myeloma,R733.3
  20. In Vitro Study of Enhancing the Cytotoxic Effect of NK Cells on Human Multiple Myeloma RPMI 8226 Cells,R733.3
  21. The Roles of PARP Inhibitor in Autophagy Induced by Doxorubicin in Multiple Myeloma Cells,R733.3

CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Bone marrow tumor
© 2012 www.DissertationTopic.Net  Mobile